Dr. Randi Hagerman joined us on November 4th to discuss the latest information and research on premutation carriers. Register below to access the on-demand recording of the webinar.
How to Watch
Enter your name and email address below for your access to the on-demand recording of the webinar:
Here are some additional resources to help you understand the Fragile X premutation and its associated disorders.
- Women’s Issues in Fragile X Spectrum Disorders
- FXTAS: New Advances and Treatments
- Our article on AGG
- FXTAS and FXPOI treatment recommendations
- General Anesthetic Use in Fragile X Spectrum Disorders
- Other Fragile X Premutation Carrier Issues
- Dr. Hagerman’s slides from this webinar
About Dr. Randi Hagerman
Dr. Hagerman is a Developmental and Behavioral Pediatrician who has worked in the fragile X field for over 30 years on both Fragile X syndrome and premutation disorders. She is at the MIND Institute at UC Davis where she holds an Endowed Chair in Fragile X Research and she runs the Clinical Trials Program and is the Medical Director of the MIND Institute. She has published over 400 articles related to fragile X and related disorders.
Recent Posts You May Be Interested In
Healx Shares their IMPACT-FXS trial
Healx Ltd presented about the IMPACT-FXS trial during the 2022 Industry Updates keynote session at the 18th International Fragile X Conference.
Asuragen Shares Their Molecular Testing Capabilities for Fragile X
Asuragen presented about the progress of Fragile X molecular testing during the 2022 Industry Updates keynote session at the 18th International Fragile X Conference.
Tetra Therapeutics Shares their BPN14770 trials
Tetra Therapeutics presented about their prior results and current BPN14770 trials during the 2022 Industry Updates keynote session at the 18th International Fragile X Conference.